AMERICAN JOURNAL OF CARDIOLOGY

Scope & Guideline

Advancing Cardiovascular Knowledge for a Healthier Tomorrow

Introduction

Welcome to your portal for understanding AMERICAN JOURNAL OF CARDIOLOGY, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN0002-9149
PublisherEXCERPTA MEDICA INC-ELSEVIER SCIENCE INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1958 to 2024
AbbreviationAM J CARDIOL / Am. J. Cardiol.
Frequency24 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807

Aims and Scopes

The American Journal of Cardiology focuses on advancing the field of cardiology through the publication of high-quality research and clinical studies. It aims to provide insights into the latest developments in cardiovascular disease management, prevention, and treatment methodologies.
  1. Cardiovascular Disease Management:
    Research related to the diagnosis, treatment, and management of various cardiovascular diseases, including coronary artery disease, heart failure, and arrhythmias.
  2. Transcatheter Procedures:
    Studies focusing on transcatheter interventions, such as transcatheter aortic valve replacement (TAVR) and catheter-based therapies for structural heart diseases.
  3. Risk Assessment and Prevention:
    Research on risk factors, prevention strategies, and management of cardiovascular disease, including lifestyle factors, pharmacological therapies, and screening methodologies.
  4. Technological Innovations:
    Investigation of new technologies and methodologies in cardiovascular imaging, surgical techniques, and device development, particularly in minimally invasive approaches.
  5. Patient Outcomes and Quality of Life:
    Studies assessing the outcomes of various treatments and interventions, including their impact on patients' quality of life and long-term health.
  6. Population Health and Disparities:
    Research addressing social determinants of health, health disparities, and the epidemiology of cardiovascular diseases across different populations.
The American Journal of Cardiology has seen an evolution in research themes, with certain areas emerging as prominent focuses of interest. These trends reflect the changing landscape of cardiovascular research and clinical practice, highlighting innovative approaches and current challenges in the field.
  1. Artificial Intelligence and Machine Learning:
    The integration of artificial intelligence (AI) and machine learning in cardiovascular research is on the rise, focusing on predictive analytics, risk stratification, and personalized medicine.
  2. Cardio-Oncology:
    Research at the intersection of cardiology and oncology is gaining momentum, focusing on the cardiovascular implications of cancer therapies and the management of patients with concurrent heart disease.
  3. Heart Failure with Preserved Ejection Fraction (HFpEF):
    Increased attention is being given to HFpEF, with studies exploring its pathophysiology, treatment strategies, and impact on patient outcomes, reflecting its growing prevalence.
  4. Telemedicine and Remote Monitoring:
    The COVID-19 pandemic has accelerated research into telemedicine and remote patient monitoring, particularly for managing chronic cardiovascular conditions and improving access to care.
  5. Patient-Centered Care:
    There is a growing emphasis on patient-reported outcomes and quality of life measures, with research increasingly focusing on how treatments affect patients' daily lives and overall well-being.

Declining or Waning

While the journal continues to publish a wide range of innovative research, certain themes have shown a decline in focus or frequency in recent years. These waning topics may reflect shifts in research priorities or advancements in understanding that have rendered previous inquiries less critical.
  1. Traditional Pharmacological Approaches:
    There has been a noticeable decrease in studies focused solely on traditional pharmacological treatments for cardiovascular disease, as newer therapies and combination strategies gain prominence.
  2. Basic Science and Pathophysiology:
    Research purely focused on basic science aspects of cardiovascular disease pathophysiology has waned, with a greater emphasis now placed on clinical applications and translational research.
  3. Single-Center Studies:
    The prevalence of studies conducted at single centers has diminished, with a shift towards larger, multicenter trials that offer broader generalizability and more robust data.
  4. Invasive Monitoring Techniques:
    There is less emphasis on traditional invasive monitoring techniques as non-invasive alternatives and advanced imaging modalities become more prevalent in clinical practice.
  5. General Cardiovascular Risk Scores:
    The use of generalized cardiovascular risk scores has declined in favor of more personalized and specific risk assessment models that take into account individual patient characteristics.

Similar Journals

Cardiovascular Revascularization Medicine

Advancing Techniques for Heart Health
Publisher: ELSEVIER INCISSN: 1553-8389Frequency: 12 issues/year

Cardiovascular Revascularization Medicine, published by Elsevier Inc, serves as a pivotal platform for research and clinical advancements in the field of cardiology and cardiovascular medicine. With an ISSN of 1553-8389 and an E-ISSN of 1878-0938, this journal has been a key resource since its inception in 2005, converging to highlight innovative approaches for cardiovascular interventions and revascularization techniques through 2024. Although it currently holds a Q3 ranking in both cardiology and general medicine categories as per the 2023 metrics, it continues to empower researchers and healthcare professionals by publishing peer-reviewed articles that bridge the gap between experimental and clinical medicine. With comprehensive coverage of emergent therapies and procedural advancements, Cardiovascular Revascularization Medicine is essential for anyone aiming to stay abreast of the evolving landscape of cardiovascular treatment. Researchers, professionals, and students alike will find invaluable insights and evidence-based research that can impact patient outcomes positively.

Korean Circulation Journal

Pioneering Insights in Cardiology and Cardiovascular Medicine.
Publisher: KOREAN SOC CARDIOLOGYISSN: 1738-5520Frequency: 12 issues/year

Korean Circulation Journal, published by the Korean Society of Cardiology, has established itself as a prominent platform for disseminating research in the fields of Cardiology and Cardiovascular Medicine. With an ISSN of 1738-5520 and an E-ISSN of 1738-5555, this journal has been at the forefront of cardiovascular science since its inception in 2006 and is projected to continue until 2024. The journal's commitment to quality is reflected in its 2023 category quartiles, ranking in the second quartile (Q2) for both Cardiology and Internal Medicine, as well as its commendable Scopus rankings within the respective fields. Located in South Korea, the journal aims to bridge the gap between cutting-edge research and practical applications, serving as an invaluable resource for researchers, healthcare professionals, and students keen on advancing their understanding of cardiovascular health. Although currently not an open-access journal, it provides a wealth of knowledge that encourages evidence-based practice in clinical settings.

Hellenic Journal of Cardiology

Connecting Researchers and Clinicians for a Stronger Heart Future
Publisher: ELSEVIERISSN: 1109-9666Frequency: 6 issues/year

The Hellenic Journal of Cardiology, a peer-reviewed open-access publication under the esteemed ELSEVIER banner, proudly represents the forefront of research in the field of Cardiology and Cardiovascular Medicine. Established in 1993 and actively publishing since then, this journal has carved a niche in disseminating high-quality research and clinical insights relevant to cardiovascular health in Greece and beyond. With an impressive Q2 ranking in both Cardiology and Cardiovascular Medicine categories as of 2023, the journal holds a commendable position at Rank #126/387 in Scopus, indicative of its critical role in advancing scientific knowledge and practice. The Hellenic Journal of Cardiology transitioned to open access in 2016, ensuring that ground-breaking research is freely accessible, fostering a global dialogue among researchers, clinicians, and students alike. Its publication frequency spans significant years, providing a continuous flow of innovative findings while addressing pressing cardiovascular issues. As the journal builds on its legacy, it aspires to enrich the academic community's understanding of cardiovascular medicine, making it an invaluable resource for anyone invested in heart health.

TEXAS HEART INSTITUTE JOURNAL

Pioneering Insights in Cardiology and Heart Health.
Publisher: TEXAS HEART INSTISSN: 0730-2347Frequency: 6 issues/year

TEXAS HEART INSTITUTE JOURNAL, published by the renowned Texas Heart Institute, stands as a pivotal resource in the field of cardiology and cardiovascular medicine. With a history spanning over four decades since its establishment in 1982, this journal addresses a wide range of topics within its scope, including clinical studies, innovative treatments, and groundbreaking research in heart health. Despite its Q3 ranking in both Cardiology and Cardiovascular Medicine, the journal is committed to fostering advancement in medical knowledge and practice, providing an essential platform for healthcare professionals and researchers alike. While currently lacking open access, the journal is recognized for its contributions to the field, aiming to illuminate critical healthcare discussions and promote the exchange of ideas. For those interested in staying at the forefront of cardiovascular research, TEXAS HEART INSTITUTE JOURNAL offers invaluable insights and the latest developments shaping the future of heart care.

Cardiology Journal

Exploring the future of cardiac science.
Publisher: VIA MEDICAISSN: 1897-5593Frequency: 6 issues/year

Cardiology Journal, published by VIA MEDICA, stands as a prominent resource in the field of cardiology and cardiovascular medicine, with an ISSN of 1897-5593 and an E-ISSN of 1898-018X. Recognized for its Open Access model established since 1994, this journal facilitates widespread dissemination of critical research findings, allowing practitioners and researchers globally to access valuable insights without barriers. Based in Poland, with an address at UL SWIETOKRZYSKA 73, 80-180 GDANSK, it has achieved a respectable Q2 classification in 2023 for both Cardiology and Miscellaneous Medicine categories, reflecting its influence and quality within the scholarly community. With a Scopus ranking placing it at #117 out of 387 in Cardiology, it lies within the 69th percentile, underpinning its commitment to advancing knowledge in cardiovascular health. The journal’s converged years extending from 2006 to 2024 ensure it captures ongoing developments in a rapidly evolving field. As such, the Cardiology Journal serves as an indispensable platform for researchers, professionals, and students dedicated to exploring the frontiers of cardiac science and improving patient care.

Cardiovascular Innovations and Applications

Advancing cardiovascular knowledge for a healthier tomorrow.
Publisher: COMPUSCRIPTISSN: 2009-8618Frequency: 1 issue/year

Cardiovascular Innovations and Applications is a premier open-access journal dedicated to advancing knowledge in the field of cardiovascular medicine. Published by COMPUSCRIPT since 2016, this journal provides a platform for the dissemination of innovative research and applications that address crucial topics in cardiology, aiming to bridge the gap between clinical practice and cutting-edge research. With an ISSN of 2009-8618 and an E-ISSN of 2009-8782, it operates on a global scale, facilitating access to high-quality content without financial barriers. The journal is positioned within the Medicine - Cardiology and Cardiovascular Medicine category, and its current Scopus rank of #321/387 reflects its potential for growth and influence in the academic community, being in the 17th percentile. Researchers, healthcare professionals, and students will find Cardiovascular Innovations and Applications an invaluable resource in their quest for the latest findings and advancements in cardiovascular health and treatment methodologies.

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Connecting Research and Practice in Cardiovascular Interventions
Publisher: WILEYISSN: 1522-1946Frequency: 14 issues/year

Catheterization and Cardiovascular Interventions is a leading peer-reviewed journal published by Wiley, dedicated to advancing the fields of cardiology, cardiovascular medicine, and radiology. With an impressive impact factor and categorized in the Q1 quartile across multiple disciplines—including Cardiology, Medicine, and Radiology—this journal serves as an essential resource for researchers, clinicians, and students interested in the latest developments in minimally invasive techniques and innovative cardiovascular therapies. Since its inception in 1999 and continuing through 2024, Catheterization and Cardiovascular Interventions has provided a platform for high-quality original research, reviews, and case studies, highlighting approaches that improve patient outcomes and treatment methodologies. Operating from the United States, the journal offers various access options, making key findings in cardiovascular interventions readily available to its audience. Stay at the forefront of cardiovascular innovation by engaging with this pivotal publication.

Journal of Cardiovascular Development and Disease

Unleashing potential through open access to groundbreaking research.
Publisher: MDPIISSN: Frequency: 12 issues/year

Journal of Cardiovascular Development and Disease, an esteemed publication by MDPI, has been a dedicated platform for disseminating cutting-edge research since its inception in 2014. Based in Switzerland, this Open Access journal not only provides unrestricted access to its content but also fosters global collaboration among scholars focusing on cardiovascular health and disease development. With an impressive focus classified as Q1 in Pharmacology, Toxicology and Pharmaceutics for 2023, it attracts a diverse range of interdisciplinary research, supporting advancements in pharmacological applications relevant to cardiac conditions. The journal's ongoing convergence through 2024 highlights its commitment to the evolving landscape of cardiovascular research, making it a vital resource for researchers, professionals, and students alike who are keen to contribute to and learn from significant developments in this critical field.

Expert Review of Cardiovascular Therapy

Transforming Cardiovascular Therapy Through Expert Review
Publisher: TAYLOR & FRANCIS INCISSN: 1477-9072Frequency: 12 issues/year

Expert Review of Cardiovascular Therapy is a leading academic journal published by TAYLOR & FRANCIS INC, focusing on innovative and impactful research in the field of cardiovascular medicine. With an ISSN of 1477-9072 and an E-ISSN of 1744-8344, this journal serves as an essential resource for researchers, clinicians, and educators, offering a platform for the dissemination of critical advancements in cardiovascular therapy and internal medicine. Since its inception in 2003, the journal has maintained a reputable standing with a Q2 ranking in various categories including Cardiology and Cardiovascular Medicine, reflecting its influence and rigor in the field. The journal, which is based in the United Kingdom, does not currently offer Open Access options, ensuring that its content is accessible primarily to subscribers. With its commitment to high-quality, peer-reviewed articles, Expert Review of Cardiovascular Therapy is dedicated to bridging the gap between experimental research and clinical application, thereby enhancing patient care and therapeutic outcomes in cardiovascular health.

Nepalese Heart Journal

Transforming Heart Health Through Research
Publisher: CARDIAC SOC NEPALISSN: 2091-2978Frequency: 1 issue/year

Nepalese Heart Journal, published by the CARDIAC SOC NEPAL, serves as a premier platform for disseminating knowledge in the field of cardiology and cardiovascular health. With an ISSN of 2091-2978, this journal aims to bridge the gap between researchers, clinicians, and academicians by presenting high-quality, peer-reviewed articles that address clinical practices, innovative research, and emerging trends in heart disease management, especially within the context of Nepal and the surrounding region. Although it operates under a traditional publishing model, its commitment to excellence aids in reinforcing the scientific discourse in an area critical to public health. The journal is a valuable resource for professionals and students alike who are focused on advancing their understanding of cardiology and its implications for health policy and practice. Exploring the intersections of local challenges and global advancements in heart health, the Nepalese Heart Journal is poised to contribute meaningfully to the evolving landscape of cardiovascular research.